Treatment Options for Molluscum Contagiosum Lesions on the Arm
Physical removal methods, including cryotherapy with liquid nitrogen, curettage, and excision, are the recommended first-line treatments for molluscum contagiosum lesions on the arm. 1
First-Line Treatment Options
- Cryotherapy with liquid nitrogen is highly effective for molluscum contagiosum lesions on the arm, with studies showing complete clearance rates of up to 94% 2
- Curettage and simple excision are effective physical removal methods recommended by the American Academy of Ophthalmology for molluscum contagiosum lesions 1
- 10% potassium hydroxide solution is a recommended first-line topical chemical treatment with similar efficacy to cryotherapy 1
- Cantharidin application has shown effectiveness in observational studies, though randomized controlled trial evidence is limited 1
Comparing Treatment Efficacy
- Cryotherapy demonstrates faster resolution compared to other treatments, with studies showing 70% of patients achieving complete clearance after just 3 weeks of treatment 3
- 10% potassium hydroxide solution has been shown to be as effective as cryotherapy in randomized clinical trials, with 86.6% complete response rate after 4 weeks 4
- 10% benzoyl peroxide cream has demonstrated superior efficacy compared to 0.05% tretinoin in treating molluscum contagiosum lesions 5
- The combination of 5% sodium nitrite with 5% salicylic acid is more effective than 5% salicylic acid alone 5
Treatment Selection Considerations
- Cryotherapy may be preferred for larger solitary lesions or when rapid treatment is desired, but carries risk of pain, bullae formation, and pigmentary changes 3
- 10% potassium hydroxide is inexpensive and provides better cosmetic results compared to cryotherapy, making it suitable for widespread lesions 4
- For multiple small lesions, topical treatments may be more practical and less painful than physical removal methods 3
- All treatment approaches should aim to identify and treat all lesions, including nascent ones, to reduce risk of recurrence 1
Important Cautions
- Imiquimod 5% cream has not shown benefit compared to placebo in randomized controlled trials and is not recommended by the American Academy of Pediatrics 1
- FDA labeling specifically states that imiquimod cream was evaluated in children with molluscum contagiosum and failed to demonstrate efficacy 6
- Cryotherapy may be associated with postinflammatory hyperpigmentation or, uncommonly, scarring 1
- Extensive or recalcitrant disease may indicate an immunocompromised state and warrant further evaluation 1
Treatment Algorithm
For limited number of lesions or when rapid treatment is desired:
For multiple or widespread lesions:
For patients concerned about pain or cosmetic outcomes: